(Q35561038)

English

Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.

scientific article published on December 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14562125%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

Europe PubMed Central

Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14562125%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

quality control

0 references

1 reference

based on heuristic

inferred from title

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14562125%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14562125%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Marcos González Díaz

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14562125%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Giuseppe Saglio

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14562125%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Jacques Van Dongen

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14562125%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Gabert J

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14562125%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Beillard E

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14562125%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

van der Velden VH

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14562125%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Bi W

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14562125%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Grimwade D

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14562125%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Pallisgaard N

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14562125%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Barbany G

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14562125%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Cazzaniga G

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14562125%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Cayuela JM

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14562125%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Pane F

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14562125%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Aerts JL

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14562125%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

De Micheli D

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14562125%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Thirion X

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14562125%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Viehmann S

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14562125%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Malec M

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14562125%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

1 December 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14562125%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14562125%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14562125%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14562125%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

2318-2357

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14562125%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Management of adult acute lymphoblastic leukemia: moving toward a risk-adapted approach

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Perspectives on the future of chronic myeloid leukemia treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the Unite

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Comparison of 'sequential' versus 'standard' chemotherapy as re-induction treatment, with or without cyclosporine, in refractory/relapsed acute myeloid leukaemia (AML): results of the UK Medical Research Council AML-R trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

New drugs for therapy of AML.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Minimal residual disease in leukaemia patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Early detection of relapse after bone marrow transplantation in patients with chronic myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Competitive CBFbeta/MYH11 reverse-transcriptase polymerase chain reaction for quantitative assessment of minimal residual disease during postremission therapy in acute myeloid leukemia with inversion(16): a pilot study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real-time quantitative RT-PCR.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Quantification of minimal residual disease in patients with e1a2 BCR-ABL-positive acute lymphoblastic leukemia using a real-time RT-PCR assay

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Quantification of CBFbeta/MYH11 fusion transcript by real time RT-PCR in patients with INV(16) acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Quantification of TEL-AML1 transcript for minimal residual disease assessment in childhood acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Rapid and sensitive minimal residual disease detection in acute leukemia by quantitative real-time RT-PCR exemplified by t(12;21) TEL-AML1 fusion transcript

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Molecular analysis of the t(1;19) breakpoint cluster region in pre-B cell acute lymphoblastic leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Hyperdiploidy and E2A-PBX1 fusion in an adult with t(1;19)+ acute lymphoblastic leukemia: case report and review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Pbx1 is converted into a transcriptional activator upon acquiring the N-terminal region of E2A in pre-B-cell acute lymphoblastoid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Transformation properties of the E2a-Pbx1 chimeric oncoprotein: fusion with E2a is essential, but the Pbx1 homeodomain is dispensable

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

E2A-Pbx1, the t(1;19) translocation protein of human pre-B-cell acute lymphocytic leukemia, causes acute myeloid leukemia in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Persistence of E2A/PBX1 transcripts in t(1;19) childhood acute lymphoblastic leukemia: correlation with chemotherapy intensity and clinical outcome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Altered Hox expression and segmental identity in Mll-mutant mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Resistance of t(4;11) (MLL-AF4 fusion gene) leukemias to stress-induced cell death: possible mechanism for extensive extramedullary accumulation of cells and poor prognosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Mechanisms of transcriptional repression by the t(8;21)-, t(12;21)-, and inv(16)-encoded fusion proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Phenotypic characterisation of a unique non-T, non-B acute lymphoblastic leukaemia cell line

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

The biology of chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Monitoring minimal residual disease in peripheral blood in B-lineage acute lymphoblastic leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Tyrosine kinase activity and transformation potency of bcr-abl oncogene products.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Residual bcr/abl transcripts in chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon alpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Kinetics of BCR-ABL fusion transcript levels in chronic myeloid leukemia patients treated with STI571 measured by quantitative real-time polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Site-specific deletions involving the tal-1 and sil genes are restricted to cells of the T cell receptor alpha/beta lineage: T cell receptor delta gene deletion mechanism affects multiple genes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

TAL1 expression does not occur in the majority of T-ALL blasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Structural characterization of SIL, a gene frequently disrupted in T-cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

RT/PCR detection of SIL-TAL-1 fusion mRNA in Chinese T-cell acute lymphoblastic leukemia (T-ALL).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Rearrangements and aberrant expression of the retinoic acid receptor alpha gene in acute promyelocytic leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Cloning and characterization of the t(15;17) translocation breakpoint region in acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

A human retinoic acid receptor which belongs to the family of nuclear receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Identification of a receptor for the morphogen retinoic acid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Translocations of the RARalpha gene in acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

The pathogenesis of acute promyelocytic leukaemia: evaluation of the role of molecular diagnosis and monitoring in the management of the disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Genomic anatomy of the specific reciprocal translocation t(15;17) in acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Pre-clinical validation of a novel, highly sensitive assay to detect PML-RARalpha mRNA using real-time reverse-transcription polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Arsenic trioxide- and idarubicin-induced remissions in relapsed acute promyelocytic leukaemia: clinicopathological and molecular features of a pilot study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Par

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Detection and quantification of CBFB/MYH11 fusion transcripts in patients with inv(16)-positive acute myeloblastic leukemia by real-time RT-PCR.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Real-time quantitative reverse transcription-polymerase chain reaction for the detection of AML1-MTG8 fusion transcripts in t(8;21)-positive acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

A quantitative reverse transcriptase polymerase chain reaction method for the detection of leukaemic cells with t(8;21) in peripheral blood

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Detection and quantification of residual disease in chronic myelogenous leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

21 January 2018

Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-alpha therapy. The Leukemia Service

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

7 January 2021

based on heuristic

inferred from DOI database lookup

Persistence of RARa‐PML fusion mRNA detected by reverse transcriptase polymerase chain reaction in patients in long‐term remission of acute promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

7 January 2021

based on heuristic

inferred from DOI database lookup

Technical aspects of quantitative competitive PCR.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular monitoring of minimal residual disease in acute myeloblastic leukemia with t(8;21) by RT-PCR

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

7 January 2021

based on heuristic

inferred from DOI database lookup

The significance of bcr-abl molecular detection in chronic myeloid leukemia patients "late," 18 months or more after transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitation of minimal residual disease in acute promyelocytic leukemia patients with t(15;17) translocation using real-time RT-PCR

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of minimal residual disease in patients with AML1/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

7 January 2021

based on heuristic

inferred from DOI database lookup

Real-time RT-PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21)-positive AML patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitation of minimal residual disease in t(8;21)-positive acute myelogenous leukemia patients using real-time quantitative RT-PCR

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

7 January 2021

based on heuristic

inferred from DOI database lookup

Real-time quantitation of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

7 January 2021

based on heuristic

inferred from DOI database lookup

Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

7 January 2021

based on heuristic

inferred from DOI database lookup

Frequent polymorphism in BCR exon b2 identified in BCR-ABL positive and negative individuals using fluorescent hybridization probes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

7 January 2021

based on heuristic

inferred from DOI database lookup

Reverse transcriptase/polymerase chain reaction follow-up and minimal residual disease detection in t(1;19)-positive acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular genetics in acute leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

7 January 2021

based on heuristic

inferred from DOI database lookup

Minimal residual disease with TEL-AML1 fusion transcript in childhood acute lymphoblastic leukaemia with t(12;21)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

7 January 2021

based on heuristic

inferred from DOI database lookup

TEL/AML1 positivity in childhood ALL: average or better prognosis? Czech Paediatric Haematology Working Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative analysis of TEL/AML1 fusion transcripts by real-time RT-PCR assay in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

7 January 2021

based on heuristic

inferred from DOI database lookup

Real-time quantitation of bcr-abl transcripts in haematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

7 January 2021

based on heuristic

inferred from DOI database lookup

Site-specific recombination of the tal-1 gene is a common occurrence in human T cell leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

7 January 2021

based on heuristic

inferred from DOI database lookup

Simultaneous SIL-TAL1 RT-PCR detection of all tal(d) deletions and identification of novel tal(d) variants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

7 January 2021

based on heuristic

inferred from DOI database lookup

The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix-loop-helix protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantification of minimal residual disease in T-lineage acute lymphoblastic leukemia with the TAL-1 deletion using a standardized real-time PCR assay

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

7 January 2021

based on heuristic

inferred from DOI database lookup

15/17 translocation, a consistent chromosomal change in acute promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

7 January 2021

based on heuristic

inferred from DOI database lookup

Pulsed ATRA as single therapy restores long-term remission in PML-RARalpha-positive acute promyelocytic leukemia patients: real time quantification of minimal residual disease. A pilot study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytogenetically cryptic AML1-ETO and CBFbeta-MYH11 gene rearrangements: incidence in 412 cases of acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of CBFbeta/MYH11 fusion transcripts in acute myeloid leukemia: heterogeneity of cytological and molecular characteristics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection and quantitation of the CBFbeta/MYH11 transcripts associated with the inv(16) in presentation and follow-up samples from patients with AML

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of minimal residual disease using reverse-transcription polymerase chain reaction in t(8;21) acute myeloid leukemia: a multicenter study of 51 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

7 January 2021

based on heuristic

inferred from DOI database lookup

Serial quantification of minimal residual disease of t(8;21) acute myelogenous leukaemia with RT-competitive PCR assay

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of nested competitive RT-PCR and real-time RT-PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21) positive acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403135

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2403135

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14562125%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

release_s2dqtw2nerdwjj7s7om5tw25am

1 reference

https://api.fatcat.wiki/v0/release/s2dqtw2nerdwjj7s7om5tw25am

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14562125%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35561038&oldid=2197481704"